Northern Trust’s Armata Pharmaceuticals ARMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$582K Buy
89,791
+65,145
+264% +$597K ﹤0.01% 3634
2026
Q1
$252K Hold
24,646
﹤0.01% 3868
2025
Q4
$155K Buy
24,646
+5,373
+28% +$29.4K ﹤0.01% 4049
2025
Q3
$57.4K Hold
19,273
﹤0.01% 4260
2025
Q2
$36.6K Hold
19,273
﹤0.01% 4281
2025
Q1
$28.1K Hold
19,273
﹤0.01% 4301
2024
Q4
$35.7K Hold
19,273
﹤0.01% 4312
2024
Q3
$45.7K Hold
19,273
﹤0.01% 4231
2024
Q2
$53K Sell
19,273
-19
-0.1% -$54 ﹤0.01% 4200
2024
Q1
$80.6K Sell
19,292
-88
-0.5% -$319 ﹤0.01% 4137
2023
Q4
$62.8K Hold
19,380
﹤0.01% 4196
2023
Q3
$58.1K Hold
19,380
﹤0.01% 4134
2023
Q2
$22.1K Hold
19,380
﹤0.01% 4391
2023
Q1
$32.4K Hold
19,380
﹤0.01% 4363
2022
Q4
$24K Hold
19,380
﹤0.01% 4453
2022
Q3
$82K Hold
19,380
﹤0.01% 4178
2022
Q2
$75K Hold
19,380
﹤0.01% 4281
2022
Q1
$95K Buy
+19,380
New +$99.3K ﹤0.01% 4353
2019
Q2
Sell
-1,482
Closed -$6K 4269
2019
Q1
$6K Hold
1,482
﹤0.01% 4192
2018
Q4
$4K Hold
1,482
﹤0.01% 4242
2018
Q3
$21K Hold
1,482
﹤0.01% 4219
2018
Q2
$23K Buy
1,482
+577
+64% +$9.39K ﹤0.01% 4204
2018
Q1
$14K Buy
+905
New +$16K ﹤0.01% 4186
2017
Q2
Sell
-155
Closed -$9K 4277
2017
Q1
$9K Buy
+155
New +$10.5K ﹤0.01% 4197

Other funds holding ARMP

Northern Trust's ARMP Position: Q2 2026 in Review

Northern Trust increased its Armata Pharmaceuticals (ARMP) stake by 264% in Q2 2026, buying an estimated $597K and bringing the position to 89,791 shares worth $582K. The position accounts for ﹤0.01% of the portfolio, ranked #3634.

Northern Trust first reported a position in ARMP in Q1 2017 and has held it in 24 quarters since. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Northern Trust held 89,791 shares of Armata Pharmaceuticals worth $582K as of Q2 2026.
  • Northern Trust bought 65,145 Armata Pharmaceuticals shares in Q2 2026, an estimated $597K.
  • Armata Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3634 holding.
  • Northern Trust first reported a position in Armata Pharmaceuticals in Q1 2017 and has held it in 24 quarters since.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.